ʻO ka2023 Nucleic Acid Medicine and mRNA Vaccine Industry Summitua mālama ʻia ma ka papahele 3 o Suzhou Nikko Hotel ma Malaki 10 ~ 11.Ua hui pū nā poʻe loea mai ka ʻāina a me nā ʻāina ʻē i ka waihona o ka lāʻau lapaʻau nucleic acid e kaʻana like i nā holomua ʻenehana hou a me ka holomua i ka R&D o Nucleic Acid Drugs.Ma kēia ʻaha kūkā, ua hōʻike kā mākou hui, ʻo Honya Biotech Co., Ltd ka mea hana nui i kono ʻia, i kā mākou huahana kumu a kaʻana like i ka ʻenehana synthesis nucleic acid hou.
I ka wā o ke kaʻina hana R&D, ka lāʻau liʻiliʻi liʻiliʻi a me ka lāʻau iomacromolecule no ka hoʻopaʻa ʻana i nā hale molecualar, ʻo ia ka "Undruggability.”;No ka RNA (ribonucleic acid), he alahaka koʻikoʻi ia e pili ana i nā genes a me nā protein, no laila ʻaʻole i kaupalena ʻia nā lāʻau nucleic acid e kona ʻano, he "druggability".Eia kekahi, ke hoʻohālikelike ʻia me ka lāʻau lapaʻau kuʻuna, ʻoi aku ka ikaika o ka lāʻau lapaʻau RNA a ʻoi aku ka lōʻihi, a ua manaʻo ʻia e lanakila i nā pilikia o ka "kūpono ʻole" o nā lāʻau lapaʻau.I kēia manawa, ʻo nā lāʻau lapaʻau mRNA, ka RNA interfering liʻiliʻi (siRNA), a me nā antisense oligonucleotides (ASO) nā ʻano nui o ka hoʻomohala ʻana i ka lāʻau lapaʻau nucleic acid i ka hana lapaʻau.
Me ka hana hou o ka gene sequencing, hoʻololi kemika a me ka ʻōnaehana hoʻopuka, ua kokoke ka lāʻau nucleic acid e hoʻomaka i kahi manawa hōʻiliʻili a manaʻo ʻia e lilo i hanauna hou o nā koho lapaʻau iterative.
Hoʻolālā ʻo Honya Biotech a kūkulu i nā DNA/RNA Synthesizers hilinaʻi a me ka hou no kahi kokoke i 10 mau makahiki.Hoʻohana nā mea kūʻai aku ma ka honua holoʻokoʻa i nā waikawa nucleic i hana ʻia e kā mākou Honya synthesizers no kā lākou kumu kūʻokoʻa.Mākou phoʻolako i nā kumu waiwai maka kiʻekiʻe no ke kahua noiʻi ʻepekema biomedical honua (noiʻi kumu, ʻike molecular, noiʻi a me ka hoʻomohala ʻana i ka waika nucleic, a me nā mea ʻē aʻe), a kōkua i ka ʻoihana biomedical e neʻe i mua.
Ka manawa hoʻouna: Mar-26-2023